Immune Design Corp Revenue and Competitors
Estimated Revenue & Valuation
- Immune Design Corp's estimated annual revenue is currently $7.5M per year. 0
- Immune Design Corp's total funding is $99M.
Employee Data
- 00
Immune Design Corp's People
| Name | Title | Email/Phone |
|---|
Immune Design Corp Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Immune Design Corp?
Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence.
keywords:N/A
$99M
Total Funding
N/A
Number of Employees
$7.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Immune Design Corp News
The cytokine tethering approach described here is designed to provide defined cytokine dosages onto adoptively transferred cells. We...
... Biomedica Management Corp, Eisai, eTheRNA Immunotherapies NV, EyeGene Inc, Formune SL, GlaxoSmithKline Plc, Harbor Therapeutics Inc, Immune Design Corp.
Adgero Biopharmaceuticals Inc, Cellceutix Corporation, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Immune Design Corp.,...
Share Share on Facebook Share on Twitter LinkedIn Email Reprints Seattle-based Immune Design imagines growing into one of the next big players in immunotherapy for cancer, and today it’s secured some big venture bucks to see if it can deliver the goods. Immune Design is announcing today it has ...
Immune Design, a Seattle, WA-based biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, closed an up to $49m Series C financing. The round was led by The Column Group and new investor Topspin Partners, and included existing in ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $90M | 0 | N/A | $13.8M |
#2 | $14.3M | 0 | N/A | $25.3M |
#3 | $9.4M | 0 | N/A | $8.6M |
#4 | $300M | 0 | N/A | $10M |
#5 | $50.8M | 0 | N/A | $29.1M |